The weekly litigation news digest is live. Subscribe now

IP Verse

Risk-Stratification Of B-Precursor Acute Lymphoblastic Leukemia Patients - EP3149480

The patent EP3149480 was granted to Amgen on Dec 26, 2018. The application was filed on May 20, 2015 under application number EP15727072A. The patent is currently recorded with a legal status of "Revoked".

EP3149480

AMGEN
Application Number
EP15727072A
Filing Date
May 20, 2015
Status
Revoked
Sep 17, 2021
Publication Date
Dec 26, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
SANOFISep 26, 2019CABINET NONYADMISSIBLE
SANOFISep 26, 2019IPSILONADMISSIBLE

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0623679
DESCRIPTIONWO2004106381
DESCRIPTIONWO2007068354
DESCRIPTIONWO2007131092
DESCRIPTIONWO2008119565
DESCRIPTIONWO2008119566
DESCRIPTIONWO2008119567
DESCRIPTIONWO2010052013
DESCRIPTIONWO2010052014
DESCRIPTIONWO2011051307
DESCRIPTIONWO2012146394
DESCRIPTIONWO9954440
OPPOSITIONWO2011051307
OPPOSITIONWO2012146394
OPPOSITIONWO2014122251

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents